Aromatic Amino Acid Metabolism in the Pathogenesis of Kwashiorkor
NCT00429351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82
Last updated 2020-02-26
Summary
This research may explain whether a shortage of three special compounds called aromatic amino acids is responsible for the severe illness and high death rate of children with the kwashiorkor type of malnutrition and whether supplying adequate amounts of these compounds in the treatment diet will speed up recovery from this condition. We propose that decreased availability of the aromatic amino acids may be the reason why children with kwashiorkor are sicker and more difficult to treat.
Conditions
- Kwashiorkor
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH -
Baylor College of Medicine
lead OTHER
Eligibility
- Min Age
- 6 Months
- Max Age
- 18 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-09-30
- Completion
- 2010-06-30
Countries
- Jamaica
More Related Trials
-
GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis
NCT01589523 ·Status: COMPLETED ·Phase: PHASE3
-
Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children
NCT04542473 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
NCT01062815 ·Status: TERMINATED ·Phase: NA
-
Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease.
NCT05093218 ·Status: UNKNOWN ·Phase: NA
-
L-carnitine Corrects Ammonia Metabolism in Hepatectomized Patients
NCT03021876 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
NCT04073368 ·Status: COMPLETED ·Phase: NA
-
N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy
NCT03499249 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
NCT04073407 ·Status: TERMINATED ·Phase: NA
-
Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia
NCT00004353 ·Status: COMPLETED
-
Branched-chain Amino Acid Supplementation for Hepatocellular Carcinoma
NCT03908255 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 2)
NCT07303868 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)
NCT00677521 ·Status: TERMINATED ·Phase: PHASE2
-
Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
NCT01191177 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients
NCT01974336 ·Status: COMPLETED ·Phase: PHASE4
-
DHA and Vitamin D in Children With Biopsy-proven NAFLD
NCT02098317 ·Status: COMPLETED ·Phase: PHASE3
-
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211 ·Status: COMPLETED ·Phase: NA
-
Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy
NCT01223742 ·Status: COMPLETED ·Phase: NA
-
Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease
NCT05922332 ·Status: WITHDRAWN ·Phase: NA
-
Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF
NCT04238416 ·Status: COMPLETED ·Phase: PHASE1
-
Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid
NCT00007020 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
NCT00004697 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)
NCT04270682 ·Status: COMPLETED ·Phase: PHASE3
-
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in Patients with Genetic Liver Disorders and Healthy Individuals
NCT06610695 ·Status: ENROLLING_BY_INVITATION
-
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
NCT01528917 ·Status: COMPLETED
-
Effects of Carnitine Supplementation on Liver and Muscle
NCT03439917 ·Status: COMPLETED ·Phase: NA